RNatives
Latest round
- Seed
Last raised
- May 2025
Total raised
- $16M
Investors
- 3
About RNatives
RNatives OY specializes in RNA therapeutics, aiming to address critical health challenges.RNatives develops precision RNA-based gene regulating therapies aimed at treating serious diseases. Their offerings include innovative RNA molecules that modulate gene expression, addressing health challenges such as genetic disorders and certain cancers.The revenue model of RNatives relies on B2B partnerships and collaborations with pharmaceutical and biotech companies. They engage in strategic alliances to co-develop RNA therapies, involving milestone-based payments tied to development achievements and potential royalties on future sales. The company is targeting growth in additional geographical markets, focusing on specific regions in North America and Asia by 2026.
Who invested in RNatives
3 investors across 1 round
See all investors in RNatives
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
May 21, 2025
Amount
$16M
Investors
Questions about RNatives
Who invested in RNatives?
RNatives has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has RNatives raised?
RNatives has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did RNatives last raise money?
RNatives's most recent round on record is a Seed, in May 2025.
What does RNatives do?
RNatives OY specializes in RNA therapeutics, aiming to address critical health challenges.
Where is RNatives headquartered?
RNatives is headquartered in Kuopio, Finland.
Which VCs invest in companies like RNatives?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back companies at RNatives's stage. Their profiles are linked below.
VCs to look at next
Raising like RNatives? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.